Cresanto Global Limited (BSE: 531207)
Health Care · Pharmaceuticals · IN
Rs—
— today · — 1Y
Cresanto Global Limited (BSE: 531207) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $239.54K.
trading between 3.83 and 5.37.
Tweenvest scores Cresanto Global Limited across four factors: quality 13/100, value 49/100. Its strongest factor is value.
531207 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $239.54K
- Revenue (TTM)
- $5.70K
- P/E
- —
- EPS
- -0.93
- Dividend yield
- —
- Beta (5Y)
- 0.02
- 52-week high
- Rs5.37
- 52-week low
- Rs3.83
- Avg volume (3M)
- —
- Shares outstanding
- 4.27M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Altamira Therapeutics Ltd.OTCPK: CYTO.F | $314.92K | $0.06 | -37.74% |
| Grapefruit USA, Inc.OTCPK: GPFT | $302.21K | $0.00 | +33.33% |
| Alterola Biotech, Inc.OTCPK: ABTI | $296.25K | $— | — |
| Wesana Health Holdings Inc.CNSX: WESA.X | $251.48K | CA$— | — |
| Ampio Pharmaceuticals, Inc.OTCPK: AMPE | $207.88K | $— | — |
| China SXT Pharmaceuticals, Inc.NasdaqCM: SXTC | $196.50K | $0.09 | -36.99% |
| GNCC Capital, Inc.OTCPK: GNCP | $174.15K | $0.00 | -99.00% |
| ProPhase Labs, Inc.OTCPK: PRPH | $163.08K | $0.01 | -43.04% |
Figures last refreshed Oct 11, 2026.